Reports
Reports
Sale
The global blood glucose test strip market size was valued at USD 20.59 billion in 2023, driven by the increasing incidence of diabetes across the globe. The market is expected to grow at a CAGR of 9.4% during the forecast period of 2024-2032, with the values likely to rise to USD 44.98 billion by 2032.
Blood glucose test strip, also known as diabetes test strip, are used to check sugar levels in the body. These strip can help people identify, monitor and control diabetes.
Blood glucose test strip are coated with a thin layer of gold. This end becomes the strip’s circuit, while the other end has a chemical coating. The latter soaks blood and converts the glucose in your blood to electricity. The electric signal travels from the strip to the meter and shows the blood sugar levels on the meter.
Every year, there are approximately 1.5 million mortalities due to diabetes. While the incidence of diabetes continues to grow, researchers suggest that early detection can lower the burden of deaths associated with the disease. Hence, there has been a significant emphasis on sugar level monitoring leading to high blood glucose test strip market demand.
The prevalence of diabetes type 1 has opened a new horizon for medical research and innovation to control the fatal disease. Owing to the technical and digital advances, smart and non-invasive glucose monitoring devices have emerged in the market. In February 2023, Apple announced that the new Apple Watch will come inbuilt with a feature that allows assessing blood sugar levels without taking a blood sample. It works with the help of a silicon photonics chip to determine the concentration of glucose levels in the body. Similarly, LifePlus, a Silicon Valley startup, is developing a non-invasive wearable wristwatch called LifeLeaf. A sensor that fits inside a smartwatch is also being developed by Afon Technology.
Considering the prevalence of non-invasive and smart technologies, the blood glucose test strip market value may appear to stumble. However, diabetes is a global disease that affects people in both high-income and low-income countries. While people may be able to afford the new technologies in developed countries, the population of low income and developing countries will prefer using blood glucose test strip as an affordable alternative for diabetes diagnosis.
Market Breakup by Type
Market Breakup by Technology
Market Breakup by Application
Market Breakup by Distribution Channel
Market Breakup by End User
Market Breakup by Region
Diabetes affects more than half of the world's population, with the current global prevalence of 6.1%. Consequently, it is the one of top leading reasons for disabilities and deaths worldwide. Type 2 diabetes contributes to 96% of the overall cases. High BMI (body mass index) is one of the key causes, followed by low physical activity, alcohol and tobacco consumption, dietary risks, and environmental risks. Given the current lifestyle, the population is more likely to develop the disease in the future. Therefore, we can expect blood glucose test strip market growth in the future.
Diabetes is particularly evident in population older than 65 years and above. As Europe and Northern America have the highest share of geriatric population, they have held a huge portion of the blood glucose test strip market share in the historic period. However, sub-Saharan Africa, Northern Africa and Western Africa are expected to witness fastest growth in the population of older people in next three decades. Hence, in the future, it has the potential to become a substantial market for blood glucose testing.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Technology |
|
Breakup by Application |
|
Breakup by Distribution Channel |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Blood Glucose Test Strip Market Overview
3.1 Global Blood Glucose Test Strip Market Historical Value (2017-2023)
3.2 Global Blood Glucose Test Strip Market Forecast Value (2024-2032)
4 Global Blood Glucose Test Strip Market Landscape
4.1 Global Blood Glucose Test Strip Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Blood Glucose Test Strip Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Application
5 Global Blood Glucose Test Strip Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Blood Glucose Test Strip Market Segmentation
6.1 Global Blood Glucose Test Strip Market by Type
6.1.1 Market Overview
6.1.2 Thick Film Electrochemical Films
6.1.3 Thin Film Electrochemical Films
6.1.4 Optical Strips
6.2 Global Blood Glucose Test Strip Market by Technology
6.2.1 Market Overview
6.2.2 Glucose Oxidase
6.2.3 Glucose Dehydrogenase
6.3 Global Blood Glucose Test Strip Market by Application
6.3.1 Market Overview
6.3.2 Type 1 Diabetes
6.3.3 Type 2 Diabetes
6.3.4 Gestational Diabetes
6.3.5 Pre-Diabetes
6.3.6 Others
6.4 Global Blood Glucose Test Strip Market by Distribution Channel
6.4.1 Market Overview
6.4.2 Online
6.4.3 Offline
6.5 Global Blood Glucose Test Strip Market by End User
6.5.1 Market Overview
6.5.2 Hospitals
6.5.3 Home Care
6.5.4 Diagnostic Laboratories
6.5.5 Others
6.6 Global Blood Glucose Test Strip Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Blood Glucose Test Strip Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Blood Glucose Test Strip Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Blood Glucose Test Strip Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Blood Glucose Test Strip Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Blood Glucose Test Strip Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Supplier Landscape
16.1 Abbott
16.1.1 Financial Analysis
16.1.2 Product Portfolio
16.1.3 Demographic Reach and Achievements
16.1.4 Mergers and Acquisitions
16.1.5 Certifications
16.2 F. Hoffmann-La Roche Ltd
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 LifeScan IP Holdings, LLC
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 i-SENS, Inc.
16.4.1 Financial Analysis
16.4.2 Financial Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.4.5 Certifications
16.5 Ascensia Diabetes Care Holdings AG
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 Universal Biosensors
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 Nipro
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 TaiDoc Technology Corporation
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9 APEX BIOTECHNOLOGY CORP.
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.9.5 Certifications
16.10 B. Braun Melsungen AG
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisitions
16.10.5 Certifications
16.11 Betachek
16.11.1 Financial Analysis
16.11.2 Product Portfolio
16.11.3 Demographic Reach and Achievements
16.11.4 Mergers and Acquisitions
16.11.5 Certifications
16.12 Terumo Corporation
16.12.1 Financial Analysis
16.12.2 Product Portfolio
16.12.3 Demographic Reach and Achievements
16.12.4 Mergers and Acquisitions
16.12.5 Certifications
16.13 OMRON Corporation
16.13.1 Financial Analysis
16.13.2 Product Portfolio
16.13.3 Demographic Reach and Achievements
16.13.4 Mergers and Acquisitions
16.13.5 Certifications
16.14 Bayer AG (Germany)
16.14.1 Financial Analysis
16.14.2 Product Portfolio
16.14.3 Demographic Reach and Achievements
16.14.4 Mergers and Acquisitions
16.14.5 Certifications
16.15 GlaxoSmithKline plc
16.15.1 Financial Analysis
16.15.2 Product Portfolio
16.15.3 Demographic Reach and Achievements
16.15.4 Mergers and Acquisitions
16.15.5 Certifications
17 Global Blood Glucose Test Strip Market - Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 20.59 billion in 2023, driven by the rising cases of diabetes across the globe.
The market is anticipated to grow at a CAGR of 9.4% during the forecast period of 2024-2032, likely to reach a market value of USD 44.98 billion by 2032.
The prevalence of a sedentary lifestyle, alcohol, and tobacco indulgence, high body mass index, and a geriatric population has led to increased incidence of diabetes and prediabetes. Hence, the demand for blood glucose test strip has increased.
With the advent of smart and non-invasive technologies, wearable and continuous glucose monitoring devices have emerged in the market. Tech companies like Apple, Samsung and Google are also developing platforms to integrate glucose monitoring sensors in their upcoming devices.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Common application areas include type 1 diabetes, type 2 diabetes, gestational diabetes, pre-diabetes, and others.
Thick film electrochemical films, thin film electrochemical films, and optical strip are different types of blood glucose test strip available.
There are both online and offline distribution channels.
Blood glucose test strip are divided into glucose oxidase and glucose dehydrogenase.
End users include hospitals, home care, and diagnostic laboratories, among others.
Key players involved in the market are Abbott, F. Hoffmann-La Roche Ltd, LifeScan IP Holdings, LLC, i-SENS, Inc., Ascensia Diabetes Care Holdings AG, Universal Biosensors, Nipro, TaiDoc Technology Corporation, APEX BIOTECHNOLOGY CORP., B. Braun Melsungen AG, Betachek, Terumo Corporation, OMRON Corporation, Bayer AG (Germany), and GlaxoSmithKline plc.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.